Brown et al. investigated intrahepatic CD4+ T cells during MASLD and HCC by focusing on the regulation of carnitine palmitoyl transferase (CPT) genes, which control the mitochondrial β-oxidation of fatty acids and act as critical molecules in lipid catabolism (Brown et al., 2018). Here, CD4 is linked to metabolic dysfunction-associated steatotic liver disease.